0001209191-19-056119.txt : 20191112 0001209191-19-056119.hdr.sgml : 20191112 20191112173555 ACCESSION NUMBER: 0001209191-19-056119 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191014 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meyer Colin John CENTRAL INDEX KEY: 0001662392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 191211034 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 BUSINESS PHONE: 972-865-2219 MAIL ADDRESS: STREET 1: 5320 LEGACY DRIVE CITY: PLANO STATE: TX ZIP: 75024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-14 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662392 Meyer Colin John 5320 LEGACY DRIVE PLANO TX 75024 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 55.73 2019-10-14 4 A 0 17750 0.00 A 2029-01-02 Class B common stock 17750 17750 D Employee Stock Option (right to buy) 55.73 2019-11-11 4 A 0 17750 0.00 A 2029-01-02 Class B common stock 17750 17750 D On January 2, 2019, the reporting person was granted an option to purchase 71,000 shares of Class B common stock. As previously reported, the option vests as to 35,500 shares in sixteen equal quarterly installments beginning on April 2, 2019, subject to continued service through each vesting date. On October 14, 2019, based on the satisfaction of certain performance criteria, the option vested as to 4,437 shares and the option was set to vest as to 13,313 shares in twelve equal quarterly installments beginning on January 14, 2020, subject to continued service through each vesting date. On November 11, 2019, based on the satisfaction of certain performance criteria, the option vested as to 4,437 shares and the option was set to vest as to 13,313 shares in twelve equal quarterly installments beginning on February 11, 2020, subject to continued service through each vesting date. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. /s/ Michael D. Wortley, attorney-in-fact 2019-11-12